Effect of Zuogui Wan on bone morphogenetic protein 2 signaling pathway in ovariectomized osteoporosis mice

doi:10.12307/2022.220

Abstract

Abstract: BACKGROUND: Postmenopausal osteoporosis is a high-incidence disease in middle-aged and elderly women, which seriously affects the quality of life. It is very necessary to discover and develop an effective prevention and treatment method. Traditional Chinese medicine can treat postmenopausal osteoporosis with tonifying kidney medicines based on the theory of “kidney governs bone,” but the molecular mechanism is still unclear.
OBJECTIVE: To observe the effect of Zuogui Wan on bone morphogenic protein 2 (BMP-2)/Runx-2/Osterix signaling pathway.
METHODS: The postmenopausal osteoporosis model was established in mice by ovarian removal. Then the successfully modeled mice were divided into model group, sham operation group, estradiol group, high-, medium- and low-dose Zuogui Wan (0.936, 0.468, 0.234 g/L) groups, and blocker group, with 12 mice per group. In the high-, medium- and low-dose Zuogui Wan groups, the corresponding concentrations of Zuogui Wan decoction were given. Sham operation group and model group were given the equal volume of normal saline. Estradiol group was given estradiol aqueous solution. The blocker group was given ICI182780 plus high-dose Zuogui Wan decoction. Intervention in each group was given via gavage for 8 continuous weeks. Immunohistochemistry and western blot were used to detect the expression of key proteins BMP-2, Runx-2 and Osterix in the tibia and femur of ovariectomized osteoporosis mice after intervention by Zuogui Wan. Changes of protein expressions in the BMP pathway were detected after blocking estrogen receptor using ICI182780.
RESULTS AND CONCLUSION: Immunohistochemical findings indicated that compared with the model group, the high and medium doses of Zuogui Wan could significantly increase the expression of BMP-2 in ovariectomized osteoporosis mice (P < 0.01, P < 0.05); the expression of Runx-2 in the medium- and low-dose Zuogui Wan groups was significantly different (P < 0.01). Western blot results showed that compared with the model group, the high and middle doses of Zuogui Wan significantly increased the expression of BMP-2 in ovariectomized osteoporosis mice (P < 0.05); the expression of Runx-2 was significantly higher in the high-, medium- and low-dose Zuogui Wan groups (P < 0.01, P < 0.05, P < 0.05); and the expression of Osterix was significantly higher in the high- and medium-dose Zuogui Wan groups (P < 0.01, P < 0.05). After ICI182780 intervention, compared with the high-dose group, the expression of BMP-2 and Runx-2 in the mouse tibia was significantly reduced in the blocker group (P < 0.05, P < 0.01) and the expression of BMP-2, Runx-2 and Osterix in the mouse femoral bones was significantly reduced in the blocker group (P < 0.01). To conclude, Zuogui Wan can participate in the regulation of bone metabolism by increasing the expression of important proteins in the BMP/Runx-2/Osterix signaling pathway in ovariectomized osteoporosis mice, thereby achieving the protection of bones.

Key words: Zuogui Wan, osteoporosis, ovariectomy, bone morphogenic protein 2, Runx-2, Osterix

CLC Number:

Li Wei, Zhu Hanmin, Wang Xin, Gao Xue, Cui Jing, Liu Yuxin, Huang Shuming. Effect of Zuogui Wan on bone morphogenetic protein 2 signaling pathway in ovariectomized osteoporosis mice[J]. Chinese Journal of Tissue Engineering Research, 2022, 26(8): 1173-1179.

Figures/Tables 8

References

[1] 赵潘婷,崔晓萍.左归丸治疗妇科疾病的研究概述[J].中国医药导报,2020,17(32):40-43.
[2] 郑鲤榕,黄惠娟.左归丸治疗骨质疏松症的方解及其药理研究[J].中国卫生产业,2012,9(15):152+154.
[3] 李建国,谢兴文,徐世红,等.经方左归丸治疗绝经后骨质疏松的研究概述[J].中国中医基础医学杂志,2019,25(5):706-709.
[4] 史晓林,王和鸣,高毅,等.绝经后骨质疏松症(骨痿)中医药诊疗指南(2019年版)[J].中医正骨,2020,32(2):1-13.
[5] KHOSLA S, MONROE DG. Regulation of Bone Metabolism by Sex Steroids. Cold Spring Harb Perspect Med. 2018;8(1):a031211.
[6] NARLA RR, OTT SM. Bones and the sex hormones. Kidney Int. 2018; 94(2):239-242.
[7] GONG W, ZHENG H, LI F, et al. Preventive and therapeutic effect of Corn CerviPantotrichum on bone tissue in ovariectomized rats through activation of BMP-2/Smads/Runx2 signal transduction pathway. Biomed Res. 2018;29(12): 2602-2608.
[8] MANIKANDAN M, ABUELREICH S, ELSAFADI M, et al. NR2F1 mediated down-regulation of osteoblast differentiation was rescued by bone morphogenetic protein-2 (BMP-2) in human MSC. Differentiation. 2018;(104):36-41.
[9] CAO X, CHEN D. The BMP signaling and in vivo bone formation. Gene. 2005;357(1):1-8.
[10] DAI J, LI Y, ZHOU H, et al. Genistein Promotion of Osteogenic Differentiation through BMP2/SMAD5/RUNX2 Signaling. Int J Biol Sci. 2013;9(10):1089-1098.
[11] 牟宏亮,吴小燕,昝强,等.左归丸治疗骨质疏松症的临床应用及实验研究进展[J].中医学报,2021,36(4):763-768.
[12] 李耀洋,尚立芝,孙河龙,等.左归丸对去势骨质疏松模型大鼠Wnt/β-catenin信号通路的影响[J].中国实验方剂学杂志,2021, 27(6):15-22.
[13] 吴佳莹,李岳泽,刘红,等.“肾主骨”机理研究—左归丸对Hepcidin、Fpn1及OPG/RANKL mRNA表达的影响[J].中国中医基础医学杂志,2017,23(11):1548-1551.
[14] 李兰,杨一秋,解继胜.去卵巢小鼠绝经后骨质疏松模型的建立和综合评定[J].右江民族医学院学报,2021,43(1):6-10.
[15] 李微,张博,李炎,等. 左归丸对卵巢摘除小鼠类雌激素样作用的实验研究[J]. 环球中医药,2018,11(2):191-195.
[16] 李微,张博,徐红丹,等. 左归丸对卵巢切除骨质疏松症模型小鼠骨代谢的影响及机制探讨[J]. 中华中医药杂志,2018,33(7):2807-2810.
[17] 黄荣兰,胡文彬,詹庆昊.中医药通过调控骨代谢相关信号通路治疗股骨头坏死的研究进展[J].中国实验方剂学杂志,2021,27(8): 241-250.
[18] 李洁,孙雅楠,解光越,等.熊果酸通过BMP-2/Smad4/Wnt/β-catenin信号通路介导对去卵巢大鼠骨量流失的保护作用[J].中国骨质疏松杂志,2020,26(12):1810-1814.
[19] 史册. Ⅰ型BMP受体介导的BMP信号在骨重塑中的作用及机理研究[D]. 长春:吉林大学,2016.
[20] DAI J, LI Y, ZHOU H, et al. Genistein Promotion of Osteogenic Differentiation through BMP2/SMAD5/RUNX2 Signaling. Int J Biol Sci. 2013;9(10):1089-1098.
[21] 刘立萍,白林峰,姜波,等.基于ER/ERK信号通路研究左归丸、左归丸去补阳药含药血清对成骨细胞功能的影响[J].中药药理与临床,2017,33(2):6-9.
[22] 段恒,周滢.左归丸对未成熟大鼠子宫发育的影响[J].世界科学技术-中医药现代化,2014,16(2):364-367.
[23] 王洪雪,王杰琼,高杰.中药治疗围绝经期综合征的机制研究[J].世界科学技术-中医药现代化,2020,22(6):1822-1827.
[24] 刘宏,易娅静,代巧妹, 等.左归丸对大鼠缺血后脑损伤的神经元保护机制[J]. 中国医科大学学报,2021,50(1):9-13.
[25] 刘宏,仲丽丽,于颖,等. 左归丸含药血清对阿尔茨海默病细胞模型雌激素受体表达的影响[J]. 中国老年学杂志,2021,41(1):141-143.
[26] 蒿长英,任艳玲,赵金茹. 左归丸含药血清通过ERK/Smads信号通路干预MC3T3-E1细胞的功能基因表达[J]. 中国药理学通报,2012, 28(6):872-876.
[27] 叶晓平,段恒. 左归丸对大鼠生殖器官发育与雌激素水平影响的实验研究[J]. 河南中医,2014,34(6):1050-1051.
[28] 刘宏,易娅静,于颖,等. 基于雌激素受体介导的神经营养因子通路探讨左归丸对脑缺血再灌注损伤的保护作用[J]. 中国医药导报, 2020,17(35):27-33.
[29] 肖艳华, 张玉梅. 左归丸联合右归丸治疗卵巢早衰前期患者对其卵巢储备功能的影响[J].中国保健营养,2017,27(36):463-464.
[30] LUO Z, LIU M, SUN L, et al.Icariin recovers the osteogenic differentiation and bone formation of bone marrow stromal cells from a rat model of estrogen deficiency-induced osteoporosis. Mol Med Rep. 2015;12(1): 382-388.